2010
Founded
1
Internally Developed Clinical
1
Marketed Products in China
0
Approved Products in US
4000 +
Global Team
OUR STORY

Breaking Boundaries

From the Beginning

From our start in Beijing with a handful of scientists and developers, to today, with a global team, a rich pipeline, strong partnerships, and commercial products. We have accomplished so much in a short time, and yet there is so much still to do.

2010

SkyHawkTX was founded as a research and development company
2010

2012

Began work on an anti-PD-1 antibody and a BTK inhibitor

2012

2014

I am timeline card content. You can change me anytime. Click here to edit this text.
2014

2016

I am timeline card content. You can change me anytime. Click here to edit this text.
2016

2019

I am timeline card content. You can change me anytime. Click here to edit this text.
2019

WHAT WE DO

Our proprietary small molecule platform targets accelerates the discovery and development of drugs that correct RNA mis-splicing across a broad range of disease types:

oncology

ONCOLOGY

neurology

NEUROLOGY

inflammatory

INFLAMMATORY INFECTIOUS RARE

neuromuscular

NEUROMUSCULAR & METABOLIC

PARTNERS

"What I love about these tours is that the guides are not afraid to get off the beaten track and show us the real city. This is an I will definitely come back to"
Alene Elvine
HR Manager
“The guide was everything I hoped for, and more. BikeTour really makes a difference, I would have never discovered the beautiful places we stopped for"
Jonas Gerber
Designer

CAREERS

Join Our Team

We’re looking for highly motivated colleagues who can collaborate with us as we build a company that will have a lasting impact on the global fight against cancer.